返回
U
University of Eastern
学者数7
论文数5
被引数0
关联论文 (5)
发表时间
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatmentMCL elderly III临床试验方案:一项国际性、随机化、开放标签的II期临床试验,旨在研究在初治且不适合剂量密集型治疗的外周细胞淋巴瘤患者中,评估venetoclax、ibrutinib和rituximab或bendamustine、ibrutinib和rituximab的联合治疗方案。
BMC Cancer
IF3.4

